Vitamin D Pilot Study in Patients With Multiple Sclerosis

Phase 1

Completed

• Conditions: Relapsing Remitting Multiple Sclerosis
• Interventions: Drug: 19 nor vitamin d

• Registration Number: NCT01257958
• Lead Sponsor: University of Wisconsin, Madison

Brief Summary

Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.

Detailed Description

Not available

Study Timeline

• Study Start: 1998-02
• Primary Completion: 2000-02
• Study Completion: 2000-06
• Status Verified: 2010-12
• Study First Submitted: 2010-12-08
• Study First Submitted QC: 2010-12-08
• Study First Posted: 2010-12-10
• Last Update Submitted: 2015-10-01
• Last Update Posted: 2015-10-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• relapsing remitting MS

Exclusion Criteria

• MRI contraindicated

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
19 nor vitamin d	19 nor vitamin d	-

Primary Outcome Measures

Name	Time	Method
MRI Measure of new active lesions, observation vs. treatment

Trial Locations

Locations (1)

UW-Madison; 🇺🇸 Madison, Wisconsin, United States